The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...

As the burden of diabetes continues to rise in India, diabetic retinopathy has emerged as one of its most debilitating complications—often leading to irreversible vision loss if left undiagnosed.

What treatment options are available for diabetic retinopathy? Dr. Daraius Shroff: The treatment of diabetes depends on the stage of diabetes and includes laser photocoagulation, intravitreal ...

Background: Diabetic retinopathy, a major microvascular complication of diabetes, significantly contributes to global blindness. Emerging evidence suggests a potential association between depression ...

It is currently scaling an AI solution that it began piloting in 2022: Digital Diagnostics’ AI system that autonomously diagnoses diabetic retinopathy. The system, called the LumineticsCore ...

The development of anti-VEGF therapies, which inhibit the growth of abnormal blood vessels in the retina, reduces the progression of diabetic ... laser photocoagulation and pan-retinal ...

Researchers from the Czech Republic, led by first author Martin Sín, MD, PhD, FEBO, reported that an AI system from Aireen exhibited greater sensitivity and specificity for screening diabetic ...

Researchers have observed in a new study that stress hyperglycemia (SHR) ratio could be a useful predictor of neovascular glaucoma (NVG) in patients with ...

Beyond macular edema, new blood vessel formation inside the eye can lead to bleeding, worsening diabetic retinopathy. To prevent this, doctors use pan-retinal photocoagulation (PRP) laser treatment, ...

We will include studies from any world region reporting diabetic retinopathy treatment coverage for one or more of: (1) laser photocoagulation; (2) intravitreal injections of antivascular endothelial ...

Department of Endocrinology, The Third Affiliated Hospital of Anhui Medical University (The First People’s Hospital of Hefei), Hefei, China Background: Diabetic retinopathy (DR) is a major contributor ...